Jiangsu Jibeier Pharmaceutical Co., Ltd. (SHA:688566)

China flag China · Delayed Price · Currency is CNY
27.63
-0.33 (-1.18%)
Apr 30, 2026, 1:54 PM CST
14.13%
Market Cap 5.58B
Revenue (ttm) 990.68M
Net Income (ttm) 254.07M
Shares Out 199.43M
EPS (ttm) 1.27
PE Ratio 22.03
Forward PE n/a
Dividend 0.78 (2.78%)
Ex-Dividend Date n/a
Volume 1,262,171
Average Volume 4,082,570
Open 27.99
Previous Close 27.96
Day's Range 27.54 - 28.06
52-Week Range 23.50 - 44.68
Beta 0.52
RSI 34.62
Earnings Date Apr 28, 2026

About SHA:688566

Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the drug research and development and production in China. The company’s products cover multiple therapeutic areas such as increasing white blood cells, fighting hypertension, enhancing immunity, treating joint diseases, fighting eye infections, treating bronchitis, protecting liver function, etc. It is also developing drugs for the treatment of depression, tumors, stomach and gastric diseases, and other diseases. In addition, the company offers its products in table... [Read more]

Sector Healthcare
Founded 2001
Employees 1,326
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688566
Full Company Profile

Financial Performance

In 2025, SHA:688566's revenue was 966.07 million, an increase of 7.76% compared to the previous year's 896.53 million. Earnings were 261.61 million, an increase of 19.28%.

Financial Statements

News

There is no news available yet.